Follow
Cytovac AB
Nasdaq First North Sweden (Sweden)
Cytovac is a growing Danish biotech company, which has chosen to focus on development of a cancer treatment that uses the body’s own immune system.
Current instruments
News
Nothing to display for this company
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
Nasdaq First North Sweden
Sweden (SE)
Details of share in Cytovac AB with ticker
Status
Active
Order book id
Amount of instruments
Par value
Market cap
Currency
SEK
Segment
First North Premier
Terms
Type
Price
Pre-money valuation
Time
Files
Listing
2020
Direct listing of Cytovac AB on Nasdaq First North Sweden
People
Jan Kuhlmann Andersen
Chairman of the board
Peter Bonne Eriksen
Board member
Per Falholt
Board member
Lars Bjerrek
Board member
Fredrik Buch
Board member
Company Details
Sector
Website

Address
Box 270
Zip code
85104
City/district
Sundsvall
Country
Sweden (SE)
Registration number
5591623318
LEI code
254900ZMD4W3LK9YET12
First trade date
Registration date
14 Jun 2018
Short name
Cytovac

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date